The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient Care

Moreover, the rapid advancements in the field of gene therapy for ADPKD suggest that this approach, though as yet only explored at experimental level, could be translated into clinical practice in future to correct the underlying genetic defect, and potentially reverse disease pathogenesis, thereby improving patient outcomes.